Company: Miramar Labs
Based: Sunnyvale, CA
Investors: Aisling Capital, Cross Creek Capital, Domain Associates, and Morgenthaler Ventures
Scoop: In a June Series C funding round, Miramar Labs, which was founded in 2006, raised about $35 million in support of its miraDry system, a device used to treat excessive underarm sweating, known as primary axillary hyperhidrosis. The company has received FDA clearance for the device and procedure, which will be launched in the U.S. in the fall.
"These funds give us the resources necessary to commercialize the miraDry system in a broad scale launch, which will enable us to provide a lasting, non-invasive solution to the many millions of people who suffer from excessive underarm sweat," said CEO Darrell Zoromski, in a release. "We're very excited to provide this procedure to physicians, and are already experiencing strong utilization in our initial launch in Tokyo, Japan."